Treatment of generalized lichen planus with alefacept

Archives of Dermatology

Volumn 142, Issue 2, 2006, Pages 151-152

  Fivenson, David P ^a,c   Mathes, Barbara ^b  

^a Fivenson Dermatology   (United States)

^b BIOGEN   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; GRISEOFULVIN; HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TSUKUBAENOLIDE;

ADULT; ALLERGY; ANAMNESIS; APOPTOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERPIGMENTATION; LICHEN PLANUS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LICHEN PLANUS; MIDDLE AGED; RECOMBINANT FUSION PROTEINS;

EID: 33244481543     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.142.2.151     Document Type: Article

References (13)

1. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991;25:593-619.
2. Lozada-Nur F, Miranda C. Oral lichen planus: topical and systemic therapy. Semin Cutan Med Surg. 1997;16:295-300.
3. Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin: a double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol. 1991;24:434-437.
4. Gorsky M, Raviv M. Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol. 1992;73:52-55.
5. Ortonne JP, Thivolet J, Sannwald C. Oral photochemotherapy in the treatment of lichen planus (LP): clinical results, histopathology and ultrastructural observations. Br J Dermatol. 1978;99:77-88.
6. Cribier B, Frances C, Chosidow O. Treatment of lichen planus: an evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521-1530.
7. Frieling U, Bonsmann G, Schwartz T, Luger TA, Beissert S. Treatment of severe lichen planus with mycophenolate mofetil. J Am Acad Dermatol. 2003;49:1063-1066.
8. Krueger GG. Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis. Expert Opin Biol Ther. 2002;2:431-441.
9. Oliver GF, Winkelmann RK, Muller SA. Lichenoid dermatitis: a clinicopathologic and immunopathologic review of sixty-two cases. J Am Acad Dermatol. 1989;21:284-292.
10. Baugh JA, Bucala R. Mechanisms for modulating TNFα in immune inflammatory disease. Curr Opin Drug Discov Devel. 2001;4:635-650.
11. Erdem MT, Gulec AI, Kiziltunc A, Yildirim A, Atasoy M. Increased serum levels of tumor necrosis factor alpha in lichen planus. Dermatology. 2003;207:367-370.
12. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol. 1999;44:499-507.
13. Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 1993;151:1548-1561.